<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of inserm-01311318</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-21T20:54:11+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Expression Profile of BCL-2, BCL-X L , and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models</title>
            <author role="aut">
              <persName>
                <forename type="first">Elizabeth</forename>
                <forename type="middle">A.</forename>
                <surname>Punnoose</surname>
              </persName>
              <idno type="halauthorid">1025535-0</idno>
              <affiliation ref="#struct-456585"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Joel</forename>
                <forename type="middle">D.</forename>
                <surname>Leverson</surname>
              </persName>
              <idno type="halauthorid">1025536-0</idno>
              <affiliation ref="#struct-456587"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Franklin</forename>
                <surname>Peale</surname>
              </persName>
              <idno type="halauthorid">1025208-0</idno>
              <affiliation ref="#struct-456588"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Erwin</forename>
                <forename type="middle">R.</forename>
                <surname>Boghaert</surname>
              </persName>
              <idno type="halauthorid">1025537-0</idno>
              <affiliation ref="#struct-456590"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Lisa</forename>
                <forename type="middle">D.</forename>
                <surname>Belmont</surname>
              </persName>
              <idno type="halauthorid">1025538-0</idno>
              <affiliation ref="#struct-456591"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nguyen</forename>
                <surname>Tan</surname>
              </persName>
              <idno type="halauthorid">1025209-0</idno>
              <affiliation ref="#struct-456591"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Amy</forename>
                <surname>Young</surname>
              </persName>
              <idno type="halauthorid">1025210-0</idno>
              <affiliation ref="#struct-456591"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Michael</forename>
                <surname>Mitten</surname>
              </persName>
              <idno type="halauthorid">1025211-0</idno>
              <affiliation ref="#struct-456588"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Ellen</forename>
                <surname>Ingalla</surname>
              </persName>
              <idno type="halauthorid">1025212-0</idno>
              <affiliation ref="#struct-456591"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Walter</forename>
                <forename type="middle">C.</forename>
                <surname>Darbonne</surname>
              </persName>
              <idno type="halauthorid">1025539-0</idno>
              <affiliation ref="#struct-456585"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Anatol</forename>
                <surname>Oleksijew</surname>
              </persName>
              <idno type="halauthorid">1025213-0</idno>
              <affiliation ref="#struct-456590"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Paul</forename>
                <surname>Tapang</surname>
              </persName>
              <idno type="halauthorid">1025214-0</idno>
              <affiliation ref="#struct-456590"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Peng</forename>
                <surname>Yue</surname>
              </persName>
              <idno type="halauthorid">1025215-0</idno>
              <affiliation ref="#struct-456591"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jason</forename>
                <surname>Oeh</surname>
              </persName>
              <idno type="halauthorid">1025216-0</idno>
              <affiliation ref="#struct-456592"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Leslie</forename>
                <surname>Lee</surname>
              </persName>
              <idno type="halauthorid">546564-0</idno>
              <affiliation ref="#struct-456592"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Sophie</forename>
                <surname>Maiga</surname>
              </persName>
              <email type="md5">32b70aa16548ee6d38fc038f9bb7d1ce</email>
              <email type="domain">univ-nantes.fr</email>
              <idno type="idhal" notation="numeric">1581766</idno>
              <idno type="halauthorid" notation="string">1006337-1581766</idno>
              <affiliation ref="#struct-218557"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Wayne</forename>
                <forename type="middle">J.</forename>
                <surname>Fairbrother</surname>
              </persName>
              <idno type="halauthorid">1025540-0</idno>
              <affiliation ref="#struct-456593"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Martine</forename>
                <surname>Amiot</surname>
              </persName>
              <email type="md5">1d59422b7c91da3e9f48381235cd5345</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="numeric">990451</idno>
              <idno type="halauthorid" notation="string">518369-990451</idno>
              <idno type="IDREF">https://www.idref.fr/121610659</idno>
              <affiliation ref="#struct-218557"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Andrew</forename>
                <forename type="middle">J.</forename>
                <surname>Souers</surname>
              </persName>
              <idno type="halauthorid">1025541-0</idno>
              <affiliation ref="#struct-456590"/>
            </author>
            <author role="crp">
              <persName>
                <forename type="first">Deepak</forename>
                <surname>Sampath</surname>
              </persName>
              <email type="md5">d55c660ce807acfc71ad8f7e2c4a9d26</email>
              <email type="domain">gene.com</email>
              <idno type="idhal" notation="numeric">981795</idno>
              <idno type="halauthorid" notation="string">1025542-981795</idno>
              <affiliation ref="#struct-456592"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Elizabeth</forename>
                <surname>Bernardo</surname>
              </persName>
              <email type="md5">373b15f895425e6af21c3cffa325a784</email>
              <email type="domain">univ-nantes.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2016-05-04 10:23:32</date>
              <date type="whenModified">2026-03-17 09:24:05</date>
              <date type="whenReleased">2016-05-04 15:34:06</date>
              <date type="whenProduced">2016</date>
              <date type="whenEndEmbargoed">9999-12-31</date>
              <ref type="file" target="https://inserm.hal.science/inserm-01311318v1/document">
                <date notBefore="9999-12-31"/>
              </ref>
              <ref type="file" subtype="author" n="1" target="https://inserm.hal.science/inserm-01311318v1/file/Mol%20Cancer%20Ther-2016-Eq%2010.pdf" id="file-1311318-1390994">
                <date notBefore="9999-12-31"/>
              </ref>
              <ref type="externalLink" target="http://mct.aacrjournals.org/content/15/5/1132.full.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="326726">
                <persName>
                  <forename>Elizabeth</forename>
                  <surname>Bernardo</surname>
                </persName>
                <email type="md5">373b15f895425e6af21c3cffa325a784</email>
                <email type="domain">univ-nantes.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">inserm-01311318</idno>
            <idno type="halUri">https://inserm.hal.science/inserm-01311318</idno>
            <idno type="halBibtex">punnoose:inserm-01311318</idno>
            <idno type="halRefHtml">&lt;i&gt;Molecular Cancer Therapeutics&lt;/i&gt;, 2016, &lt;a target="_blank" href="https://dx.doi.org/10.1158/1535-7163.MCT-15-0730"&gt;&amp;#x27E8;10.1158/1535-7163.MCT-15-0730&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Molecular Cancer Therapeutics, 2016, &amp;#x27E8;10.1158/1535-7163.MCT-15-0730&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-1311318-1390994"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="UNIV-NANTES">Université de Nantes</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-ANGERS">Université d'Angers</idno>
            <idno type="stamp" n="CRCNA">Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS</idno>
            <idno type="stamp" n="CRCI2NA">Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes-Angers</idno>
            <idno type="stamp" n="NANTES-UNIVERSITE">Nantes Université</idno>
            <idno type="stamp" n="UNIV-NANTES-AV2022">Université de Nantes</idno>
            <idno type="stamp" n="UFR-MEDECINE-NANTES">UFR de médecine - Nantes Université</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Expression Profile of BCL-2, BCL-X L , and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Elizabeth</forename>
                    <forename type="middle">A.</forename>
                    <surname>Punnoose</surname>
                  </persName>
                  <idno type="halauthorid">1025535-0</idno>
                  <affiliation ref="#struct-456585"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Joel</forename>
                    <forename type="middle">D.</forename>
                    <surname>Leverson</surname>
                  </persName>
                  <idno type="halauthorid">1025536-0</idno>
                  <affiliation ref="#struct-456587"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Franklin</forename>
                    <surname>Peale</surname>
                  </persName>
                  <idno type="halauthorid">1025208-0</idno>
                  <affiliation ref="#struct-456588"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Erwin</forename>
                    <forename type="middle">R.</forename>
                    <surname>Boghaert</surname>
                  </persName>
                  <idno type="halauthorid">1025537-0</idno>
                  <affiliation ref="#struct-456590"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Lisa</forename>
                    <forename type="middle">D.</forename>
                    <surname>Belmont</surname>
                  </persName>
                  <idno type="halauthorid">1025538-0</idno>
                  <affiliation ref="#struct-456591"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nguyen</forename>
                    <surname>Tan</surname>
                  </persName>
                  <idno type="halauthorid">1025209-0</idno>
                  <affiliation ref="#struct-456591"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Amy</forename>
                    <surname>Young</surname>
                  </persName>
                  <idno type="halauthorid">1025210-0</idno>
                  <affiliation ref="#struct-456591"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Michael</forename>
                    <surname>Mitten</surname>
                  </persName>
                  <idno type="halauthorid">1025211-0</idno>
                  <affiliation ref="#struct-456588"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Ellen</forename>
                    <surname>Ingalla</surname>
                  </persName>
                  <idno type="halauthorid">1025212-0</idno>
                  <affiliation ref="#struct-456591"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Walter</forename>
                    <forename type="middle">C.</forename>
                    <surname>Darbonne</surname>
                  </persName>
                  <idno type="halauthorid">1025539-0</idno>
                  <affiliation ref="#struct-456585"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Anatol</forename>
                    <surname>Oleksijew</surname>
                  </persName>
                  <idno type="halauthorid">1025213-0</idno>
                  <affiliation ref="#struct-456590"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Paul</forename>
                    <surname>Tapang</surname>
                  </persName>
                  <idno type="halauthorid">1025214-0</idno>
                  <affiliation ref="#struct-456590"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Peng</forename>
                    <surname>Yue</surname>
                  </persName>
                  <idno type="halauthorid">1025215-0</idno>
                  <affiliation ref="#struct-456591"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jason</forename>
                    <surname>Oeh</surname>
                  </persName>
                  <idno type="halauthorid">1025216-0</idno>
                  <affiliation ref="#struct-456592"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Leslie</forename>
                    <surname>Lee</surname>
                  </persName>
                  <idno type="halauthorid">546564-0</idno>
                  <affiliation ref="#struct-456592"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Sophie</forename>
                    <surname>Maiga</surname>
                  </persName>
                  <email type="md5">32b70aa16548ee6d38fc038f9bb7d1ce</email>
                  <email type="domain">univ-nantes.fr</email>
                  <idno type="idhal" notation="numeric">1581766</idno>
                  <idno type="halauthorid" notation="string">1006337-1581766</idno>
                  <affiliation ref="#struct-218557"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Wayne</forename>
                    <forename type="middle">J.</forename>
                    <surname>Fairbrother</surname>
                  </persName>
                  <idno type="halauthorid">1025540-0</idno>
                  <affiliation ref="#struct-456593"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Martine</forename>
                    <surname>Amiot</surname>
                  </persName>
                  <email type="md5">1d59422b7c91da3e9f48381235cd5345</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="numeric">990451</idno>
                  <idno type="halauthorid" notation="string">518369-990451</idno>
                  <idno type="IDREF">https://www.idref.fr/121610659</idno>
                  <affiliation ref="#struct-218557"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Andrew</forename>
                    <forename type="middle">J.</forename>
                    <surname>Souers</surname>
                  </persName>
                  <idno type="halauthorid">1025541-0</idno>
                  <affiliation ref="#struct-456590"/>
                </author>
                <author role="crp">
                  <persName>
                    <forename type="first">Deepak</forename>
                    <surname>Sampath</surname>
                  </persName>
                  <email type="md5">d55c660ce807acfc71ad8f7e2c4a9d26</email>
                  <email type="domain">gene.com</email>
                  <idno type="idhal" notation="numeric">981795</idno>
                  <idno type="halauthorid" notation="string">1025542-981795</idno>
                  <affiliation ref="#struct-456592"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">17165</idno>
                <idno type="issn">1535-7163</idno>
                <idno type="eissn">1538-8514</idno>
                <title level="j">Molecular Cancer Therapeutics</title>
                <imprint>
                  <publisher>American Association for Cancer Research</publisher>
                  <date type="datePub">2016</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1158/1535-7163.MCT-15-0730</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BCL-2 family proteins dictate survival of human multiple myeloma cells, making them attractive drug targets. Indeed, multiple myeloma cells are sensitive to antagonists that selectively target prosurvival proteins such as BCL-2/BCL-X L (ABT-737 and ABT-263/navitoclax) or BCL-2 only (ABT-199/GDC-0199/vene-toclax). Resistance to these three drugs is mediated by expression of MCL-1. However, given the selectivity profile of venetoclax it is unclear whether coexpression of BCL-X L also affects antitumor responses to venetoclax in multiple myeloma. In multiple mye-loma cell lines (n ¼ 21), BCL-2 is expressed but sensitivity to venetoclax correlated with high BCL-2 and low BCL-X L or MCL-1 expression. Multiple myeloma cells that coexpress BCL-2 and BCL-X L were resistant to venetoclax but sensitive to a BCL-X L – selective inhibitor (A-1155463). Multiple myeloma xenograft models that coexpressed BCL-X L or MCL-1 with BCL-2 were also resistant to venetoclax. Resistance to venetoclax was mitigated by cotreatment with bortezomib in xenografts that coex-pressed BCL-2 and MCL-1 due to upregulation of NOXA, a proapoptotic factor that neutralizes MCL-1. In contrast, xeno-grafts that expressed BCL-X L , MCL-1, and BCL-2 were more sensitive to the combination of bortezomib with a BCL-X L selective inhibitor (A-1331852) but not with venetoclax cotreatment when compared with monotherapies. IHC of multiple myeloma patient bone marrow biopsies and aspirates (n ¼ 95) revealed high levels of BCL-2 and BCL-X L in 62% and 43% of evaluable samples, respectively, while 34% were characterized as BCL-2 High /BCL-X L Low. In addition to MCL-1, our data suggest that BCL-X L may also be a potential resistance factor to venetoclax monotherapy and in combination with bortezomib. Mol Cancer Ther; 15(5); 1–13. Ó2016 AACR.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="department" xml:id="struct-456585" status="INCOMING">
          <orgName>Oncology Biomarkers</orgName>
          <desc>
            <address>
              <addrLine>South San Francisco, CA 94080</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-98288" type="direct"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456587" status="INCOMING">
          <orgName>Oncology Development</orgName>
          <desc>
            <address>
              <addrLine>1400 Sheridan Rd, North Chicago, IL 60064</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-456586" type="direct"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456588" status="INCOMING">
          <orgName>Research Pathology</orgName>
          <desc>
            <address>
              <addrLine>South San Francisco, CA 94080</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-98288" type="direct"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456590" status="INCOMING">
          <orgName>Oncology Discovery</orgName>
          <desc>
            <address>
              <addrLine>1400 Sheridan Rd, North Chicago, IL 60064</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-456589" type="direct"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456591" status="INCOMING">
          <orgName>Discovery Oncology</orgName>
          <desc>
            <address>
              <addrLine>South San Francisco, CA 94080</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-98288" type="direct"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456592" status="INCOMING">
          <orgName>Translational Oncology</orgName>
          <desc>
            <address>
              <addrLine>South San Francisco, CA 94080</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-98288" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-218557" status="OLD">
          <orgName>Centre de Recherche en Cancérologie Nantes-Angers</orgName>
          <orgName type="acronym">CRCNA</orgName>
          <date type="end">2016-12-31</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-74911" type="direct"/>
            <relation active="#struct-151939" type="direct"/>
            <relation name="U892" active="#struct-303623" type="direct"/>
            <relation name="UMR6299" active="#struct-441569" type="direct"/>
            <relation active="#struct-474972" type="direct"/>
            <relation active="#struct-531638" type="direct"/>
            <relation active="#struct-93263" type="indirect"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-456593" status="INCOMING">
          <orgName>Early Discovery Biochemistry</orgName>
          <desc>
            <address>
              <addrLine>South San Francisco, CA 94080</addrLine>
              <country key="US"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-98288" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-98288" status="VALID">
          <orgName>Genentech, Inc.</orgName>
          <desc>
            <address>
              <addrLine>1 DNA Way South San Francisco, CA 94080-4990</addrLine>
              <country key="US"/>
            </address>
            <ref type="url">http://www.gene.com/gene/index.jsp</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-456586" status="VALID">
          <orgName>Abbvie Inc. [North Chicago]</orgName>
          <desc>
            <address>
              <addrLine>1400 Sheridan Rd, North Chicago, IL 60064</addrLine>
              <country key="US"/>
            </address>
            <ref type="url">https://www.abbvie.com/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-456589" status="INCOMING">
          <orgName>Abbvie Inc.: North Chicago</orgName>
          <desc>
            <address>
              <addrLine>1400 Sheridan Rd, North Chicago, IL 60064</addrLine>
              <country key="US"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-74911" status="VALID">
          <idno type="IdRef">026402920</idno>
          <idno type="ISNI">0000000122483363</idno>
          <idno type="ROR">https://ror.org/04yrqp957</idno>
          <orgName>Université d'Angers</orgName>
          <orgName type="acronym">UA</orgName>
          <date type="start">1971-10-25</date>
          <desc>
            <address>
              <addrLine>Université d'Angers - 40 Rue de Rennes, BP 73532 - 49035 Angers CEDEX 01</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-angers.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-151939" status="VALID">
          <idno type="ISNI">0000 0004 0472 0283</idno>
          <idno type="ROR">https://ror.org/0250ngj72</idno>
          <orgName>Centre Hospitalier Universitaire d'Angers</orgName>
          <orgName type="acronym">CHU Angers</orgName>
          <desc>
            <address>
              <addrLine>4 rue Larrey - 49933 Angers cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-angers.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-474972" status="VALID">
          <idno type="IdRef">034926445</idno>
          <idno type="ROR">https://ror.org/05c1qsg97</idno>
          <idno type="Wikidata">Q2945767</idno>
          <orgName>Centre Hospitalier Universitaire de Nantes = Nantes University Hospital</orgName>
          <orgName type="acronym">CHU Nantes</orgName>
          <desc>
            <address>
              <addrLine>1 Place Alexis-Ricordeau, 44000 Nantes</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-nantes.fr</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-531638" status="OLD">
          <idno type="IdRef">076954927</idno>
          <orgName>Université de Nantes - UFR de Médecine et des Techniques Médicales</orgName>
          <orgName type="acronym">UFR MEDECINE</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>1 rue Gaston Veil BP 53508 44035 NANTES Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.medecine.univ-nantes.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-93263" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-93263" status="OLD">
          <idno type="IdRef">026403447</idno>
          <idno type="ROR">https://ror.org/03gnr7b55</idno>
          <orgName>Université de Nantes</orgName>
          <orgName type="acronym">UN</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-nantes.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>